| 注册
首页|期刊导航|中国临床药理学与治疗学|参附注射液对乳腺癌术后化疗患者生存质量及其免疫功能的影响研究

参附注射液对乳腺癌术后化疗患者生存质量及其免疫功能的影响研究

陈舟 黄和 陈其余

中国临床药理学与治疗学2018,Vol.23Issue(10):1159-1164,6.
中国临床药理学与治疗学2018,Vol.23Issue(10):1159-1164,6.DOI:10.12092/j.issn.1009-2501.2018.10.012

参附注射液对乳腺癌术后化疗患者生存质量及其免疫功能的影响研究

Effects of Shenfu injection on the quality of life and immune function on patients with breast cancer after chemotherapy

陈舟 1黄和 1陈其余1

作者信息

  • 1. 温州医科大学附属第一医院药学部,温州325000,浙江
  • 折叠

摘要

Abstract

AIM: To study the effect of Shenfu injection on the quality of life and immune function in patients with breast cancer after chemotherapy. METHODS: A total of 150 patients with breast cancer who received chemotherapy in our hospital from Dec. 2016 to Dec. 2017 were selected and ran-domly divided into the study group and the control group according to the random number table meth-od. The control group was given conventional chem-otherapy; the study group received extra Shenfu in-jection treatment on the basis of the control group. After 6 courses of chemotherapy, the clinical effica-cy of the two groups was compared. The T cell sub-group, NK cell level, immunoglobulin level and the quality of life of the two groups were analyzed before and after chemotherapy and the occurrence of ad-verse reactions was observed. RESULTS:The total effective rate of the study group was 96% , which was significantly higher than that of the control group (86. 67% ) ( P < 0. 05 ). Before chemotherapy, there was no significant difference in the levels of CD3 +, CD4 +, CD8 +, CD4 +/CD8 +and NK cells between the two groups ( P >0. 05 ) . After chemo-therapy, the level of CD3 +, CD4 +, CD4 +/CD8 +and NK cells in the two groups increased, and the increase of the study group was higher than that of the control group. The level of CD8 +decreased and the decrease of the study group was lower than the control group. The two groups were significantly dif-ferent (P <0. 05). After chemotherapy, the lgG, lgA and lgM level of the two groups decreased, and the study group decreased more than the control group (P <0. 05). After chemotherapy, the score of somatic function in the functional subscale of the study group was significantly higher than that of the control group. The scores of fatigue, nausea, vomi-ting and pain in the symptom subscale were signifi-cantly lower than those of the control group ( P <0. 05) . The total adverse reaction rate in the study group was 4% , which was significantly lower than that in the control group (14. 67% ) . There was a significant difference between the two groups ( P <0. 05). CONCLUSION:Shenfu injection can effec-tively improve the immune function of patients with breast cancer after chemotherapy, and improve the quality of life after operation. The clinical effect is remarkable and worthy of clinical application.

关键词

参附注射液/乳腺癌/化疗/生存质量/免疫功能

Key words

Shenfu injection/breast cancer/chemotherapy/quality of life/immune function

分类

医药卫生

引用本文复制引用

陈舟,黄和,陈其余..参附注射液对乳腺癌术后化疗患者生存质量及其免疫功能的影响研究[J].中国临床药理学与治疗学,2018,23(10):1159-1164,6.

中国临床药理学与治疗学

OACSCDCSTPCD

1009-2501

访问量0
|
下载量0
段落导航相关论文